60.05

8.45% -5.54

Pre-market: 61.10 1.05 +1.75%

Genedx Holdings Corp (WGS)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Genedx Holdings Corp stock is traded at $60.05, with a volume of 1.01M. It is down -8.45% in the last 24 hours and down -36.46% over the past month. GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

Previous Close:

$65.59

Open:

$64.2

24h Volume:

1.01M

Relative Volume:

1.30

Market Cap:

$1.76B

Revenue:

$427.54M

Net Income/Loss:

$-21.02M

P/E Ratio:

-80.93

EPS:

-0.742

Net Cash Flow:

$14.26M

1W Performance:

-9.29%

1M Performance:

-36.46%

6M Performance:

-52.65%

1Y Performance:

-38.28%

1-Day Range:

$57.71

$64.64

1-Week Range:

$57.71

$72.00

52-Week Range:

$55.17

$170.87

Genedx Holdings Corp Stock (WGS) Company Profile

Name

Genedx Holdings Corp

Sector

Healthcare (1107)

Industry

Diagnostics & Research (52)

Phone

888-729-1206

Address

333 LUDLOW STREET, STAMFORD

Employee

1,300

Twitter

Next Earnings Date

2025-02-18

Latest SEC Filings

WGS's Discussions on Twitter

Compare WGS vs TMO, DHR, IDXX, A, WAT

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
WGS Genedx Holdings Corp	60.05	1.92B	427.54M	-21.02M	14.26M	-0.742
TMO Thermo Fisher Scientific Inc	500.46	187.10B	44.56B	6.72B	6.29B	17.74
DHR Danaher Corp	192.99	138.84B	24.57B	3.60B	5.26B	5.051
IDXX Idexx Laboratories Inc	584.75	47.01B	4.30B	1.06B	1.04B	13.08
A Agilent Technologies Inc	115.39	33.04B	7.07B	1.29B	993.00M	4.5355
WAT Waters Corp	317.65	31.25B	3.17B	642.63M	516.49M	10.77

Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-26	Upgrade	Wells Fargo	Equal Weight → Overweight
Oct-20-25	Initiated	Canaccord Genuity	Buy
Jul-09-25	Initiated	Piper Sandler	Overweight
May-15-25	Initiated	Guggenheim	Buy
May-09-25	Upgrade	Jefferies	Hold → Buy
Aug-28-24	Initiated	Wells Fargo	Equal Weight
Jul-10-24	Initiated	Craig Hallum	Buy
Jun-03-24	Resumed	Jefferies	Hold

View All

Genedx Holdings Corp Stock (WGS) Latest News

Apr 09, 2026

Cathie Wood’s ARK sells BWX Technologies stock, buys GeneDx - Investing.com

Apr 09, 2026

Insider Trends: Can GeneDx Holdings Corp deliver alphaTrade Exit Report & Fast Exit/Entry Strategy Plans - baoquankhu1.vn

Apr 09, 2026

GeneDx Stock Plunges 8.9% on Analyst Downgrades - National Today

Apr 09, 2026

Apr 08, 2026

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - The Motley Fool

Apr 08, 2026

Swing Trade: How does GeneDx Holdings Corp score in quality rankingsWeekly Profit Analysis & Reliable Momentum Entry Alerts - baoquankhu1.vn

Apr 08, 2026

Apr 06, 2026

Stock Recap: Is GeneDx Holdings Corp Equity Warrant stock showing strong momentum2026 Performance Recap & Stepwise Trade Signal Implementation - baoquankhu1.vn

Apr 06, 2026

Are Institutional Outflows Quietly Rewriting GeneDx (WGS)’s Genomics‑and‑AI Investment Story? - Sahm

Apr 06, 2026

Apr 04, 2026